Cite
APA Citation
Overman, M. J., Adam, L., Raghav, K., Wang, J., Kee, B., Fogelman, D., Eng, C., Vilar, E., Shroff, R., Dasari, A., Wolff, R., Morris, J., Karunasena, E., Pisanic, R., Azad, N., & Kopetz, S. (2018). phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. Annals of oncology, 29, 139–144. http://access.bl.uk/ark:/81055/vdc_100095512160.0x00002e